Published in Antimicrob Agents Chemother on August 13, 2012
Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases. World J Gastroenterol (2016) 0.75
In vitro Synergism between Chloroquine and Antibiotics against Orientia tsutsugamushi. Infect Chemother (2014) 0.75
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (1981) 19.90
Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21
Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev (1997) 10.52
Endocytosis and the recycling of plasma membrane. J Cell Biol (1983) 10.24
Shigella flexneri induces apoptosis in infected macrophages. Nature (1992) 6.26
Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol (2007) 5.13
Curcumin: the Indian solid gold. Adv Exp Med Biol (2007) 4.12
Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med (2000) 3.91
Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med (2002) 3.31
Exit strategies of intracellular pathogens. Nat Rev Microbiol (2008) 2.27
The rab7 GTPase controls the maturation of Salmonella typhimurium-containing vacuoles in HeLa cells. EMBO J (1999) 2.17
Mechanisms of pathogen entry through the endosomal compartments. Nat Rev Mol Cell Biol (2006) 2.16
Pathogenic trickery: deception of host cell processes. Nat Rev Mol Cell Biol (2001) 1.95
SlyA, a transcriptional regulator of Salmonella typhimurium, is required for resistance to oxidative stress and is expressed in the intracellular environment of macrophages. Infect Immun (1997) 1.94
Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol (1991) 1.84
The design and synthesis of polymers for eukaryotic membrane disruption. J Control Release (1999) 1.77
Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clin Immunol (2005) 1.76
Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest (1991) 1.68
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest (1994) 1.56
Curcumin-artemisinin combination therapy for malaria. Antimicrob Agents Chemother (2006) 1.51
Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother (2009) 1.45
Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J (2008) 1.45
Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. J Clin Invest (1997) 1.43
Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother (2006) 1.40
Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. Infect Immun (1998) 1.36
Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol (1998) 1.34
Host-pathogen interactions: the seduction of molecular cross talk. Gut (2002) 1.24
Macrophages inhibit Salmonella typhimurium replication through MEK/ERK kinase and phagocyte NADPH oxidase activities. J Biol Chem (2002) 1.17
Intracellular survival of Shigella. Cell Microbiol (2006) 1.16
Dual role for macrophages in vivo in pathogenesis and control of murine Salmonella enterica var. Typhimurium infections. Eur J Immunol (2000) 1.01
Characterization of the membrane-destabilizing properties of different pH-sensitive methacrylic acid copolymers. Biochim Biophys Acta (2003) 1.01
Staphylococcus aureus escapes more efficiently from the phagosome of a cystic fibrosis bronchial epithelial cell line than from its normal counterpart. Infect Immun (2006) 1.00
The interplay between Salmonella typhimurium and its macrophage host--what can it teach us about innate immunity? Immunol Lett (2003) 0.98
Biochemical characterization and inhibitor discovery of shikimate dehydrogenase from Helicobacter pylori. FEBS J (2006) 0.98
Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol (1999) 0.97
Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3. Antimicrob Agents Chemother (1990) 0.96
Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model. Lab Invest (2008) 0.89
Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis. Infect Immun (1999) 0.89
Multifaceted roles of curcumin: two sides of a coin! Expert Opin Biol Ther (2011) 0.87
Divergent roles of Salmonella pathogenicity island 2 and metabolic traits during interaction of S. enterica serovar typhimurium with host cells. PLoS One (2012) 0.85
Photokilling of bacteria by the natural dye curcumin. Arch Microbiol (1989) 0.84
Y. enterocolitica inhibits antigen degradation in dendritic cells. Microbes Infect (2008) 0.82
Curcumin increases the pathogenicity of Salmonella enterica serovar Typhimurium in murine model. PLoS One (2010) 0.82
Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression. PLoS One (2010) 0.81
Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. Inflammation (1996) 0.81
Bactericidal effect of hydrogen peroxide on Salmonella typhimurium in liquid whole egg. J Appl Bacteriol (1987) 0.76
Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol (2008) 1.81
Novel role of the nitrite transporter NirC in Salmonella pathogenesis: SPI2-dependent suppression of inducible nitric oxide synthase in activated macrophages. Microbiology (2009) 1.77
Acidic pH induced STM1485 gene is essential for intracellular replication of Salmonella. Virulence (2012) 1.48
Vaccine with herbal adjuvant--a better cocktail to combat the infection. Vaccine (2008) 1.43
Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog (2010) 1.39
Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond. Vaccine (2008) 1.35
Intracellular activities of Salmonella enterica in murine dendritic cells. Cell Microbiol (2003) 1.33
The yejABEF operon of Salmonella confers resistance to antimicrobial peptides and contributes to its virulence. Microbiology (2008) 1.22
Role of neutrophils in murine salmonellosis. Infect Immun (2004) 1.11
Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1. Proc Natl Acad Sci U S A (2013) 1.07
Arginase modulates Salmonella induced nitric oxide production in RAW264.7 macrophages and is required for Salmonella pathogenesis in mice model of infection. Microbes Infect (2008) 0.99
Functional transfer of Salmonella pathogenicity island 2 to Salmonella bongori and Escherichia coli. Infect Immun (2004) 0.99
Pathogen-specific TLR2 protein activation programs macrophages to induce Wnt-beta-catenin signaling. J Biol Chem (2011) 0.98
Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella typhimurium and Salmonella typhi. J Antimicrob Chemother (2012) 0.97
Visiting the cell biology of Salmonella infection. Microbes Infect (2010) 0.93
Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo. Antimicrob Agents Chemother (2013) 0.93
Bactericidal/permeability increasing protein: a multifaceted protein with functions beyond LPS neutralization. Innate Immun (2012) 0.92
lac repressor is an antivirulence factor of Salmonella enterica: its role in the evolution of virulence in Salmonella. PLoS One (2009) 0.90
Differentially evolved genes of Salmonella pathogenicity islands: insights into the mechanism of host specificity in Salmonella. PLoS One (2008) 0.90
Needleless vaccine delivery using micro-shock waves. Clin Vaccine Immunol (2011) 0.90
Multifaceted roles of curcumin: two sides of a coin! Expert Opin Biol Ther (2011) 0.87
Reliable means of diagnosis and serovar determination of blood-borne Salmonella strains: quick PCR amplification of unique genomic loci by novel primer sets. J Clin Microbiol (2009) 0.87
Biocides--resistance, cross-resistance mechanisms and assessment. Expert Opin Investig Drugs (2012) 0.87
Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model. Vaccine (2007) 0.86
Salmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid. PLoS One (2011) 0.86
Cationic amino acid transporters and Salmonella Typhimurium ArgT collectively regulate arginine availability towards intracellular Salmonella growth. PLoS One (2010) 0.85
Salmonella enterica serovars Typhimurium and Typhi as model organisms: revealing paradigm of host-pathogen interactions. Virulence (2012) 0.85
A safe vaccine (DV-STM-07) against Salmonella infection prevents abortion and confers protective immunity to the pregnant and new born mice. PLoS One (2010) 0.85
Typhoid fever & vaccine development: a partially answered question. Indian J Med Res (2012) 0.85
Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages. Infect Immun (2012) 0.84
Bacterial transformation using micro-shock waves. Anal Biochem (2011) 0.84
Division of the Salmonella-containing vacuole and depletion of acidic lysosomes in Salmonella-infected host cells are novel strategies of Salmonella enterica to avoid lysosomes. Infect Immun (2009) 0.84
Role of actin cytoskeleton in LPS-induced NF-kappaB activation and nitric oxide production in murine macrophages. Innate Immun (2008) 0.83
The LysR-type transcriptional regulator Hrg counteracts phagocyte oxidative burst and imparts survival advantage to Salmonella enterica serovar Typhimurium. Microbiology (2008) 0.83
Detection of microorganisms using biosensors-a smarter way towards detection techniques. Biosens Bioelectron (2009) 0.82
Host-specificity of Salmonella enterica serovar Gallinarum: insights from comparative genomics. Infect Genet Evol (2009) 0.82
SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria. Vaccine (2009) 0.82
Lactoylglutathione lyase, a critical enzyme in methylglyoxal detoxification, contributes to survival of Salmonella in the nutrient rich environment. Virulence (2015) 0.82
Curcumin increases the pathogenicity of Salmonella enterica serovar Typhimurium in murine model. PLoS One (2010) 0.82
TLR 9 activation in dendritic cells enhances salmonella killing and antigen presentation via involvement of the reactive oxygen species. PLoS One (2010) 0.81
Folimycin (concanamycin A) inhibits LPS-induced nitric oxide production and reduces surface localization of TLR4 in murine macrophages. Innate Immun (2008) 0.80
Cells producing their own nemesis: understanding methylglyoxal metabolism. IUBMB Life (2014) 0.79
Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsules. Int J Nanomedicine (2013) 0.78
Effectors of Salmonella pathogenicity island 2: An island crucial to the life of Salmonella. Virulence (2011) 0.78
Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella. J Antimicrob Chemother (2013) 0.77
Development of micro-shock wave assisted dry particle and fluid jet delivery system. Appl Microbiol Biotechnol (2012) 0.77
Curcumin! Spicy panacea for all--friend or foe. Vaccine (2009) 0.77
Salmonella Typhimurium: insight into the multi-faceted role of the LysR-type transcriptional regulators in Salmonella. Int J Biochem Cell Biol (2009) 0.77
TolA mediates the differential detergent resistance pattern between the Salmonella enterica subsp. enterica serovars Typhi and Typhimurium. Microbiology (2011) 0.76
New tricks new ways: exploitation of a multifunctional enzyme arginase by pathogens. Virulence (2010) 0.76
Non-neutral evolution in non-LEE-encoded type III effectors of attaching and effacing Escherichia coli. Microbes Infect (2012) 0.76
Herbal cocktail as anti-infective: promising therapeutic for the treatment of viral diseases. Recent Pat Antiinfect Drug Discov (2012) 0.76
Immunomodulation using agonists and antagonists: potential clinical applications. Expert Opin Investig Drugs (2011) 0.75
The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens. Expert Opin Biol Ther (2014) 0.75
Altering the balance between pathogen containing vacuoles and lysosomes: a lesson from Salmonella. Virulence (2010) 0.75